Skip to content

Virtual Reality for Dental Anxiety in Children With Mild Intellectual Disability

Effect of Virtual Reality on Dental Anxiety in Children With Mild Intellectual Disability: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07249359
Acronym
VR-MID
Enrollment
56
Registered
2025-11-25
Start date
2025-02-01
Completion date
2025-09-30
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intellectual Disabilities (F70-F79)

Brief summary

Virtual reality (VR) is a promising non-pharmacological approach to reduce dental anxiety in children with neurodevelopmental disorders. This randomized controlled trial compared a VR-based distraction intervention with conventional monitor-based distraction in children aged 11-15 years with mild intellectual disability and moderate dental anxiety undergoing conservative dental treatment.

Interventions

immersive VR software delivered through Meta Quest 3® headset during dental procedure

DEVICEControl: Monitor-Based Distraction

cartoon video displayed in front of dental chair

Sponsors

Oasi Research Institute-IRCCS
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Age 11-15; diagnosis of mild intellectual disability (DSM-5) * Moderate anxiety (Corah DAS 9-12) * ≥1 decayed tooth requiring conservative treatment under local anesthesia * Informed consent from parents/legal guardians

Exclusion criteria

* no or slight anxiety * high or severe anxiety * visual disorders * neuromuscular comorbidities interfering with cooperation

Design outcomes

Primary

MeasureTime frameDescription
Treatment successDuration of procedureNumber of patients with completion of restorative dental procedure under local anesthesia within 50 minutes and positive overall treatment experience (dichotomous: success vs. failure)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026